CIS
GH icon

Capital International Sarl’s Guardant Health GH Stock Holding History

Capital International Sarl’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,033
Closed -$252K – 250
2021
Q2 		$252K Buy
2,033
+75
+4% +$10.1K 0.02% 236
2021
Q1 		$299K Hold
1,958
– – 0.03% 226
2020
Q4 		$252K Buy
+1,958
New +$225K 0.03% 217

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Capital International Sarl's GH Position: Q3 2021 in Review

Capital International Sarl sold out of Guardant Health (GH) in Q3 2021, closing a stake of 2,033 shares — an estimated $252K sold.

Capital International Sarl first reported a position in GH in Q4 2020 and held it in 3 quarters. The position peaked at $299K in Q1 2021. 374 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Capital International Sarl reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Capital International Sarl sold 2,033 Guardant Health shares in Q3 2021, an estimated $252K.
  • Capital International Sarl first reported a position in Guardant Health in Q4 2020 and held it in 3 quarters.
  • Capital International Sarl's Guardant Health position peaked at $299K in Q1 2021.
  • 374 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Capital International Sarl's 13F filing for Q3 2021, filed 15 Nov 2021.